Premium
E-Z-EM (MM) (EZEM)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
E-Z-EM, Inc. (NASDAQ: EZEM) announced today it had completed the merger of Eagle Acquisition Sub, Inc., a wholly owned subsidiary of Bracco Diagnostics, Inc. (Bracco), the...
E-Z-EM, Inc. (NASDAQ: EZEM) announced today that the stockholders of the Company voted to adopt the merger agreement providing for the acquisition of the Company by Bracco...
E-Z-EM, Inc. (NASDAQ:EZEM) today announced financial results for the quarter and first half of 2008 ending December 1, 2007. Highlights of the fiscal year 2008 second quarter...
E-Z-EM, Inc. (NASDAQ:EZEM) today announced financial results for its fiscal 2007 fourth quarter and fiscal year. Highlights for the quarter ended June 2, 2007 and recent weeks...
E-Z-EM, Inc. (NASDAQ:EZEM) today announced that the U.S. Army Space & Missile Defense Command (USASMD) has placed an additional order for the Company?s RSDLTM personal skin...
E-Z-EM, Inc. (NASDAQ:EZEM) today announced preliminary financial results for its 2007 fiscal year-end. The Company expects net sales of approximately $137.8 million and net...
E-Z-EM, Inc., (NASDAQ:EZEM) today announced that Tyco Healthcare Group LP filed a lawsuit against the Company in the federal district court in Texas alleging patent infringement...
Stock exchange and ticker symbol in release dated May 8, 2007 should read: (NASDAQ:EZEM). The corrected release reads: ADEL MICHAEL JOINS E-Z-EM BOARD OF DIRECTORS...
E-Z-EM, Inc. (NASDAQ:EZEM) today announced that Dennis J. Curtin, Senior Vice President-Chief Financial Officer (CFO), has resigned to pursue other opportunities. Joseph...
E-Z-EM, Inc. (NASDAQ:EZEM) today announced that the Company has received 510(k) clearance from the Food and Drug Administration (FDA) for its EmpowerMRTM injector system?the...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
